Skip to content

Clinical trials

Observational Hepatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Observational Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20041
20091
20113
20121
20132
20143
20181
20191
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting3
Terminated3
Unknown status2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
National Institutes of Health Clinical Center (CC)2
University of North Carolina, Chapel Hill2
Centers for Disease Control and Prevention1
Dynavax Technologies Corporation1
Foundation for the National Institutes of Health1
Gilead Sciences1
Icahn School of Medicine at Mount Sinai1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis26
Hepatitis C7
Liver Diseases7
Hepatitis B6
Fibrosis4
Virus Diseases4
Liver Cirrhosis3
Non-alcoholic Fatty Liver Disease3
Carcinoma, Hepatocellular2
Celiac Disease2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.